BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17443289)

  • 1. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
    Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
    J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
    Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo-A expression in oligodendroglial tumors.
    Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
    Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.
    Smith SF; Simpson JM; Brewer JA; Sekhon LH; Biggs MT; Cook RJ; Little NS
    J Neurooncol; 2006 Oct; 80(1):75-82. PubMed ID: 16794749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):140-7. PubMed ID: 22648019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
    Geevar T; Pai R; Chacko G; Malepathi K; Patel B; John J; Chacko AG; Balakrishnan R; John S
    Neurol India; 2018; 66(6):1726-1731. PubMed ID: 30504574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
    Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
    Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
    Karjalainen SL; Haapasalo HK; Aspatwar A; Barker H; Parkkila S; Haapasalo JA
    BMC Cancer; 2018 May; 18(1):584. PubMed ID: 29792187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.
    Cryan JB; Haidar S; Ramkissoon LA; Bi WL; Knoff DS; Schultz N; Abedalthagafi M; Brown L; Wen PY; Reardon DA; Dunn IF; Folkerth RD; Santagata S; Lindeman NI; Ligon AH; Beroukhim R; Hornick JL; Alexander BM; Ligon KL; Ramkissoon SH
    Oncotarget; 2014 Sep; 5(18):8083-92. PubMed ID: 25257301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.
    Chaudhry IH; O'Donovan DG; Brenchley PE; Reid H; Roberts IS
    Histopathology; 2001 Oct; 39(4):409-15. PubMed ID: 11683943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
    Kouwenhoven MC; Gorlia T; Kros JM; Ibdaih A; Brandes AA; Bromberg JE; Mokhtari K; van Duinen SG; Teepen JL; Wesseling P; Vandenbos F; Grisold W; Sipos L; Mirimanoff R; Vecht CJ; Allgeier A; Lacombe D; van den Bent MJ
    Neuro Oncol; 2009 Dec; 11(6):737-46. PubMed ID: 19224764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.